Süleyman Demir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Süleyman Demir has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Rukiye Nar
Pamukkale University, Denizli, Turkey
2 shared publications - Ahmet Küçük
University of Health Sciences, Konya Beyhekim Training and Research Hospital, Neurology Clinic, Konya, Türkiye
1 shared publication - Anna Maria Paganoni
Politecnico di Milano
1 shared publication - Aysen Cetin Kardesler
Biochemistry Pamukkale Univercity Denizli Turkey
1 shared publication - Belda Dursun
Division of Nephrology, Department of Internal Medicine,Faculty of Medicine, Pamukkale University, Denizli, Türkiye
1 shared publication Elif Basak
The School of Medicine, Department of Medical Biochemistry, Pamukkale University, Denizli
1 shared publication
Latest Publications
- 29 March 2025
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 85 (2) , e70014
Evaluation of Orexin‐A, Adiponectin and Apelin‐13 Serum Levels in Children Diagnosed With Attention Deficit Hyperactivity Disorder
Objective: This study investigates the role of orexin‐a, adiponectin (HMWA) and apelin‐13 serum levels in the etiopathogenesis of attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder with unclear aetiology involving neuropathological, genetic and environmental factors.Methods: The study involved 37 children with ADHD and 35 healthy controls, aged 6–18 years, with no history of other physical or psychiatric illnesses and no psychotropic medication use in the last 6 months. Serum levels of orexin‐a, adiponectin (HMWA) and apelin‐13 were measured using enzyme‐linked immunosorbent assay (ELISA). ADHD symptoms were assessed through Diagnostic and Statistical Manual of Mental Disorders‐5 (DSM‐5)–based clinical interviews, Conners Parent and Teacher Rating Scales and Wisconsin Card Sorting Test.Results: No significant differences in serum orexin‐a, adiponectin (HMWA) and apelin‐13 levels were found between the ADHD and control groups. Additionally, there was no relationship between orexin‐a, apelin‐13 and adinopectin levels and ADHD symptoms and Wisconsin Card Sorting Test results. Analysis of adiponectin levels in preadolescent children aged 6–11, adjusting for age and BMI, revealed a statistically significant reduction in the ADHD group (p = 0.002).Conclusion: The results did not demonstrate any correlation between ADHD and the levels of orexin‐a and apelin‐13. However, the study revealed that children with ADHD, aged 6–11, exhibited decreased adiponectin concentrations. These results suggest that a decrease in serum adinopectin levels may be associated with ADHD in children.
- 29 March 2025
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 85 (2) , e70014
Evaluation of Orexin‐A, Adiponectin and Apelin‐13 Serum Levels in Children Diagnosed With Attention Deficit Hyperactivity Disorder
Objective: This study investigates the role of orexin‐a, adiponectin (HMWA) and apelin‐13 serum levels in the etiopathogenesis of attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder with unclear aetiology involving neuropathological, genetic and environmental factors.Methods: The study involved 37 children with ADHD and 35 healthy controls, aged 6–18 years, with no history of other physical or psychiatric illnesses and no psychotropic medication use in the last 6 months. Serum levels of orexin‐a, adiponectin (HMWA) and apelin‐13 were measured using enzyme‐linked immunosorbent assay (ELISA). ADHD symptoms were assessed through Diagnostic and Statistical Manual of Mental Disorders‐5 (DSM‐5)–based clinical interviews, Conners Parent and Teacher Rating Scales and Wisconsin Card Sorting Test.Results: No significant differences in serum orexin‐a, adiponectin (HMWA) and apelin‐13 levels were found between the ADHD and control groups. Additionally, there was no relationship between orexin‐a, apelin‐13 and adinopectin levels and ADHD symptoms and Wisconsin Card Sorting Test results. Analysis of adiponectin levels in preadolescent children aged 6–11, adjusting for age and BMI, revealed a statistically significant reduction in the ADHD group (p = 0.002).Conclusion: The results did not demonstrate any correlation between ADHD and the levels of orexin‐a and apelin‐13. However, the study revealed that children with ADHD, aged 6–11, exhibited decreased adiponectin concentrations. These results suggest that a decrease in serum adinopectin levels may be associated with ADHD in children.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
Comparison of Urine Drug Abuse Testing Analyzed in Glass and Plastic Tubes
Kullanımının tespiti amacıyla kullanılmaktadır. Biz bu çalışmada idrarda madde analizinde ucuz ve pratik olan plastik tüplerin cam tüplere alternatif olup olamayacağını araştırmayı amaçladık. Gereç ve Yöntem: 80 yetişkin gönüllüden alınan taze idrar örnekleri cam ve plastik tüplere aktarıldı ve örneklerde idrar bütünlük testleri çalışılarak örneklerin uygunlukları değerlendirildi. Ardından idrarda amfetaminler (AMP), benzodiazepinler (BNZ), kokain (COC), opiatlar (OPI) ve kannabinoidlerin (THC) düzeyi Roche Cobas c 501’de immünoanaliz yöntemiyle yarı kantitatif olarak ölçüldü. Testin pozitifliği için kesim değerleri; AMP> 500μg/L, BNZ> 300μg/L, COC> 150μg/L, OPI> 2000μg/L ve THC> 50μg/L olarak alındı. İdrar örneklerinin bekletilmesinin test sonucuna etkisini araştırmak için, numunelerden 32 tanesi herhangi bir koruyucu madde olmadan dört saat bekletildi ve tekrar analiz edildi. Verilerin analizinde SPSS 25.0 programı kullanıldı. Bulgular: AMP, BNZ, COC, OPI ve THC konsantrasyonlarında cam ve plastik tüpler arasında anlamlı bir fark yoktu. OPI açısından istatistiksel olarak anlamlı fark bulundu (p= 0.005) ancak OPI düzeylerindeki değişiklik klinik kararı (pozitiflik) değiştirmedi. Her iki tüpte de aynı analit ölçümüne ilişkin tüm sonuçlar arasında anlamlı yüksek korelasyon vardı (p= 0.0001). Bekletilen idrar numunelerinde (n= 32) sadece BNZ plastik tüpte istatistiksel olarak anlamlı yüksek bulundu (p= 0.037); ancak bu farklılıklar örneklerin pozitifliğini veya negatifliğini değiştirmedi ve klinik olarak anlamsızdı. Tüm testler için tüp türleri ve süre açısından örnekler karşılaştırıldığında anlamlı korelasyonlar mevcuttu (p <0.001). Sonuç: Bu çalışmanın sonucunda, kötüye kullanılan ilaçların analizinde cam tüpler yerine plastik tüplerin kullanılabileceği, oda sıcaklığında dört saat saklandıktan sonra madde konsantrasyonlarında anlamlı bir değişimin olmadığı sonucu çıkarılabilir.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
Comparison of Urine Drug Abuse Testing Analyzed in Glass and Plastic Tubes
Kullanımının tespiti amacıyla kullanılmaktadır. Biz bu çalışmada idrarda madde analizinde ucuz ve pratik olan plastik tüplerin cam tüplere alternatif olup olamayacağını araştırmayı amaçladık. Gereç ve Yöntem: 80 yetişkin gönüllüden alınan taze idrar örnekleri cam ve plastik tüplere aktarıldı ve örneklerde idrar bütünlük testleri çalışılarak örneklerin uygunlukları değerlendirildi. Ardından idrarda amfetaminler (AMP), benzodiazepinler (BNZ), kokain (COC), opiatlar (OPI) ve kannabinoidlerin (THC) düzeyi Roche Cobas c 501’de immünoanaliz yöntemiyle yarı kantitatif olarak ölçüldü. Testin pozitifliği için kesim değerleri; AMP> 500μg/L, BNZ> 300μg/L, COC> 150μg/L, OPI> 2000μg/L ve THC> 50μg/L olarak alındı. İdrar örneklerinin bekletilmesinin test sonucuna etkisini araştırmak için, numunelerden 32 tanesi herhangi bir koruyucu madde olmadan dört saat bekletildi ve tekrar analiz edildi. Verilerin analizinde SPSS 25.0 programı kullanıldı. Bulgular: AMP, BNZ, COC, OPI ve THC konsantrasyonlarında cam ve plastik tüpler arasında anlamlı bir fark yoktu. OPI açısından istatistiksel olarak anlamlı fark bulundu (p= 0.005) ancak OPI düzeylerindeki değişiklik klinik kararı (pozitiflik) değiştirmedi. Her iki tüpte de aynı analit ölçümüne ilişkin tüm sonuçlar arasında anlamlı yüksek korelasyon vardı (p= 0.0001). Bekletilen idrar numunelerinde (n= 32) sadece BNZ plastik tüpte istatistiksel olarak anlamlı yüksek bulundu (p= 0.037); ancak bu farklılıklar örneklerin pozitifliğini veya negatifliğini değiştirmedi ve klinik olarak anlamsızdı. Tüm testler için tüp türleri ve süre açısından örnekler karşılaştırıldığında anlamlı korelasyonlar mevcuttu (p <0.001). Sonuç: Bu çalışmanın sonucunda, kötüye kullanılan ilaçların analizinde cam tüpler yerine plastik tüplerin kullanılabileceği, oda sıcaklığında dört saat saklandıktan sonra madde konsantrasyonlarında anlamlı bir değişimin olmadığı sonucu çıkarılabilir.
- Open Access
- 9 September 2024
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 17 (4) , 11
Controlling nutritional (CONUT) score for nutritional screening in kidney transplant recipients
Purpose: Nutrition is severely impaired in individuals with renal impairment, and transplant often ameliorates this condition. In this study, we aimed to evaluate the controlling nutritional status (CONUT) score of kidney transplant (KT) recipients. Materials and methods: Using the data from the nephrology transplant unit, we analyzed 188 patients whose data on the constituents of the CONUT score were available. We included KT individuals with at least one lymphocyte count and total cholesterol and albumin concentrations. This data has been used to calculate the CONUT score. The decrease of lymphocyte counts and total cholesterol was determined with 0, 1, 2, and 3 points, and the reduction of albumin was assigned with 0, 2, 4, and 6 points in agreement with disease severity. Patients were classified according to this score: normal, light, moderate, and severe. Results: There were 138 patients in normal, 54 in light, and three in each moderate and severe group. The CONUT score was good for regular-weight patients both before and after transplantation. All laboratory findings revealed significant differences between CONUT groups (p< 0.05). The logistic regression analysis model, including cholesterol, WBC, and calcium, showed that these three parameters have a predictive value of 80%. Conclusion: After transplantation, the number of patients in the underweight group decreased when normal weight and obesity increased. However, some patients’ nutrition was not ameliorated. The CONUT score may be a useful tool for monitoring transplant patients’ nutritional status.
- 9 September 2024
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 17 (4) , 11
Open AccessControlling nutritional (CONUT) score for nutritional screening in kidney transplant recipients
Purpose: Nutrition is severely impaired in individuals with renal impairment, and transplant often ameliorates this condition. In this study, we aimed to evaluate the controlling nutritional status (CONUT) score of kidney transplant (KT) recipients. Materials and methods: Using the data from the nephrology transplant unit, we analyzed 188 patients whose data on the constituents of the CONUT score were available. We included KT individuals with at least one lymphocyte count and total cholesterol and albumin concentrations. This data has been used to calculate the CONUT score. The decrease of lymphocyte counts and total cholesterol was determined with 0, 1, 2, and 3 points, and the reduction of albumin was assigned with 0, 2, 4, and 6 points in agreement with disease severity. Patients were classified according to this score: normal, light, moderate, and severe. Results: There were 138 patients in normal, 54 in light, and three in each moderate and severe group. The CONUT score was good for regular-weight patients both before and after transplantation. All laboratory findings revealed significant differences between CONUT groups (p< 0.05). The logistic regression analysis model, including cholesterol, WBC, and calcium, showed that these three parameters have a predictive value of 80%. Conclusion: After transplantation, the number of patients in the underweight group decreased when normal weight and obesity increased. However, some patients’ nutrition was not ameliorated. The CONUT score may be a useful tool for monitoring transplant patients’ nutritional status.
- 11 April 2022
- Published by Walter de Gruyter GmbH in Hormone Molecular Biology and Clinical Investigation
- Vol. 43 (3) , 281-288
Serum 25(OH) vitamin D level in Relapsing-Remitting Multiple Sclerosis and clinically isolated syndrome groups
Objectives: Vitamin D is an important regulator of the immune system, and it has been shown that deficiency of vitamin D is significant environmental factor in some immune-mediated diseases such as Multiple Sclerosis (MS). In this study, we have compared serum 25 hydroxyvitamin (OH) D levels in Relapsing-Remitting Multiple Sclerosis (RRMS), clinically isolated syndrome (CIS), and control groups. Methods: Forty patients with CIS and 60 patients who have been diagnosed RRMS between age 18–45, respectively, and followed up at Pamukkale University Faculty of Medicine, Department of Neurology, and 60 healthy individuals have been included in this study. Serum 25(OH) vitamin D, calcium, phosphorus, alkaline phosphatase, parathormone, insulin, and fasting blood glucose levels were studied for all three groups. Results: A statistically significant difference was determined in the comparison of three groups for mean 25(OH) vitamin D levels. In the intergroup comparison of mean 25(OH) vitamin D; mean 25(OH) vitamin D level was determined to be statistically significantly lower in both RRMS and CIS groups compared to control group (p<0.05). Conclusions: Since vitamin D deficiency poses a problem from the early stage of disease spectrum in both CIS patients and MS patients, 25(OH) vitamin D level should be routinely controlled, and replacement should be administered upon any deficiency state.
- 11 April 2022
- Published by Walter de Gruyter GmbH in Hormone Molecular Biology and Clinical Investigation
- Vol. 43 (3) , 281-288
Serum 25(OH) vitamin D level in Relapsing-Remitting Multiple Sclerosis and clinically isolated syndrome groups
Objectives: Vitamin D is an important regulator of the immune system, and it has been shown that deficiency of vitamin D is significant environmental factor in some immune-mediated diseases such as Multiple Sclerosis (MS). In this study, we have compared serum 25 hydroxyvitamin (OH) D levels in Relapsing-Remitting Multiple Sclerosis (RRMS), clinically isolated syndrome (CIS), and control groups. Methods: Forty patients with CIS and 60 patients who have been diagnosed RRMS between age 18–45, respectively, and followed up at Pamukkale University Faculty of Medicine, Department of Neurology, and 60 healthy individuals have been included in this study. Serum 25(OH) vitamin D, calcium, phosphorus, alkaline phosphatase, parathormone, insulin, and fasting blood glucose levels were studied for all three groups. Results: A statistically significant difference was determined in the comparison of three groups for mean 25(OH) vitamin D levels. In the intergroup comparison of mean 25(OH) vitamin D; mean 25(OH) vitamin D level was determined to be statistically significantly lower in both RRMS and CIS groups compared to control group (p<0.05). Conclusions: Since vitamin D deficiency poses a problem from the early stage of disease spectrum in both CIS patients and MS patients, 25(OH) vitamin D level should be routinely controlled, and replacement should be administered upon any deficiency state.
- 30 January 2018
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 43 (5) , 487-494
Evaluation of the relationship between TNFα, sTNFR1, sTNFR2, sIL2R, IL6, neopterin with disease activity in ankylosing spondylitis
Objective: We aimed to evaluate the relationship among TNFα, sTNFR1, sTNFR2, sIL2R, IL6, neopterin and disease activity in ankylosing spondylitis (AS). Materials and methods: TNFα, sTNFR1, sTNFR2, sIL2R, IL6 and neopterin were measured in patients and controls. Patients were grouped according to disease activity and medication. Results: Neopterin and sTNFR1 were not different while TNFα, sTNFR2, sIL2R and IL6 were high in patients than controls. There was no difference between active and inactive patients for TNFα, sIL2R and IL6. sTNFR2 was significantly lower in active patients. There was no relationship between CRP positivity and disease activity. AS patient groups are; 1: TNF blockers, 2: nonsteroidal anti-inflammatory drugs (NSAIDs), 3: disease modifying anti-rheumatic drugs (DMARDs), 4: TNF blockers and NSAIDs, 5: DMARDs and NSAIDs. sTNFR2 was significantly lower in active patients than in inactive, in Group 1. ESR levels were significantly lower in inactive patients compared to active in group 3 and 4. There was no significant association between CRP positivity and disease activity. Conclusion: According to our study, CRP is insufficient in evaluating AS disease activity. ESR can be useful in evaluating the disease activity. sTNFR2 might be useful as a biological indicator of disease activity in AS treated with TNF inhibitors alone.
- 30 January 2018
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 43 (5) , 487-494
Evaluation of the relationship between TNFα, sTNFR1, sTNFR2, sIL2R, IL6, neopterin with disease activity in ankylosing spondylitis
Objective: We aimed to evaluate the relationship among TNFα, sTNFR1, sTNFR2, sIL2R, IL6, neopterin and disease activity in ankylosing spondylitis (AS). Materials and methods: TNFα, sTNFR1, sTNFR2, sIL2R, IL6 and neopterin were measured in patients and controls. Patients were grouped according to disease activity and medication. Results: Neopterin and sTNFR1 were not different while TNFα, sTNFR2, sIL2R and IL6 were high in patients than controls. There was no difference between active and inactive patients for TNFα, sIL2R and IL6. sTNFR2 was significantly lower in active patients. There was no relationship between CRP positivity and disease activity. AS patient groups are; 1: TNF blockers, 2: nonsteroidal anti-inflammatory drugs (NSAIDs), 3: disease modifying anti-rheumatic drugs (DMARDs), 4: TNF blockers and NSAIDs, 5: DMARDs and NSAIDs. sTNFR2 was significantly lower in active patients than in inactive, in Group 1. ESR levels were significantly lower in inactive patients compared to active in group 3 and 4. There was no significant association between CRP positivity and disease activity. Conclusion: According to our study, CRP is insufficient in evaluating AS disease activity. ESR can be useful in evaluating the disease activity. sTNFR2 might be useful as a biological indicator of disease activity in AS treated with TNF inhibitors alone.
- Open Access
- 1 January 2015
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 53 (s1)
Data generation, Bioinformatics, information technology, big data
- 1 January 2015
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 53 (s1)
Open AccessData generation, Bioinformatics, information technology, big data